| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8688485 | NeuroImage: Clinical | 2017 | 8 Pages |
Abstract
Neurodegeneration, indicated by volume loss and myelin reductions, is evident in major brainstem pathways and nuclei following traumatic SCI; the magnitude of these changes relating to clinical impairment. Thus, quantitative MRI protocols offer new targets, which may be used as neuroimaging biomarkers in treatment trials.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Patrick Grabher, Claudia Blaiotta, John Ashburner, Patrick Freund,